POSTNATAL DEPRESSION
Clinical trials for POSTNATAL DEPRESSION explained in plain language.
Never miss a new study
Get alerted when new POSTNATAL DEPRESSION trials appear
Sign up with your email to follow new studies for POSTNATAL DEPRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Mindfulness may ease Post-Baby blues without meds
Symptom relief CompletedThis study tested whether an 8-week mindfulness program could help new mothers with depressive symptoms. 70 Chinese women who had given birth within the past 1.5 years and had mild to moderate depression took part. Half attended weekly mindfulness sessions; the other half receive…
Matched conditions: POSTNATAL DEPRESSION
Phase: NA • Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated May 17, 2026 08:03 UTC
-
Singing together online lifts postnatal depression in new moms
Symptom relief CompletedThis study tested whether online group singing classes could help new mothers with postnatal depression. 37 women with babies up to 9 months old joined 6 weekly Zoom singing sessions. The goal was to see if their depression symptoms improved, building on earlier in-person researc…
Matched conditions: POSTNATAL DEPRESSION
Phase: NA • Sponsor: King's College London • Aim: Symptom relief
Last updated May 17, 2026 07:59 UTC
-
New pill aims to lift the fog of postpartum depression
Symptom relief CompletedThis study tested an oral medication called LPCN 1154A in 90 women with severe postpartum depression. The goal was to see if it reduces depressive and anxiety symptoms better than a placebo. Participants took the drug or a dummy pill, and researchers measured mood changes using a…
Matched conditions: POSTNATAL DEPRESSION
Phase: PHASE3 • Sponsor: Lipocine Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
New pill aims to ease severe postpartum depression in just 3 days
Symptom relief CompletedThis study tested an experimental oral drug called NORA520 in 93 women with severe postpartum depression. Participants took the drug or a placebo for 3 days to see if it safely reduces depressive symptoms. The goal is to find a fast-acting, well-tolerated treatment for new mother…
Matched conditions: POSTNATAL DEPRESSION
Phase: PHASE2 • Sponsor: DuKang Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 13, 2026 15:58 UTC